Admissibility of scientific testimony into evidence.
Brushwood
D B
DB
Health Care Administration, University of Florida, Gainesville 32610.
D000014:Abnormalities, Drug-Induced; D000932:Antiemetics / Q000009:adverse effects*; D004025:Dicyclomine; D004319:Doxylamine / Q000009:adverse effects*; D004338:Drug Combinations; D004345:Drug Industry / Q000331:legislation & jurisprudence; D005104:Expert Testimony; D005260:Female; D006801:Humans; D011247:Pregnancy; D011736:Pyridoxine / Q000009:adverse effects*; D013723:Teratogens; D014481:United States
D000932:Antiemetics; D004338:Drug Combinations; D013723:Teratogens; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine